| Major lipids, apolipoproteins, and risk of vascular disease R Assessment Jama 302 (18), 1993-2000, 2009 | 3056 | 2009 |
| C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Emerging Risk Factors Collaboration The Lancet 375 (9709), 132-140, 2010 | 2749 | 2010 |
| Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis FS Collaboration Jama 294 (14), 1799-1809, 2005 | 1662 | 2005 |
| Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta … S Kaptoge, IR White, SG Thompson, AM Wood, S Lewington, GD Lowe, ... American journal of epidemiology 166 (8), 867-879, 2007 | 289 | 2007 |
| Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data Direct Thrombin Inhibitor Trialists' Collaborative Group The Lancet 359 (9303), 294-302, 2002 | 211 | 2002 |
| Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry M Haim, M Benderly, D Brunner, S Behar, E Graff, H Reicher-Reiss, ... Circulation 100 (5), 475-482, 1999 | 208 | 1999 |
| Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction EZ Fisman, M Benderly, RJ Esper, S Behar, V Boyko, Y Adler, D Tanne, ... The American journal of cardiology 98 (1), 14-18, 2006 | 180 | 2006 |
| Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level A Hiuge, A Tenenbaum, N Maeda, M Benderly, M Kumada, EZ Fisman, ... Arteriosclerosis, Thrombosis, and Vascular Biology 27 (3), 635-641, 2007 | 172 | 2007 |
| Fibrinogen is a predictor of mortality in coronary heart disease patients M Benderly, E Graff, H Reicher-Reiss, S Behar, D Brunner, U Goldbourt Arteriosclerosis, thrombosis, and vascular biology 16 (3), 351-356, 1996 | 172 | 1996 |
| Oral antidiabetic treatment in patients with coronary disease: time‐related increased mortality on combined glyburide/metformin therapy over a 7.7‐year follow‐up EZ Fisman, A Tenenbaum, Y Adler, M Motro, V Boyko, M Benderly, ... Clinical cardiology 24 (2), 151-158, 2001 | 124 | 2001 |
| Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events GDO Lowe, A Rumley Thrombosis and haemostasis 82 (08), 667-672, 1999 | 118 | 1999 |
| Update on the use of fibrates: focus on bezafibrate I Goldenberg, M Benderly, U Goldbourt Vascular health and risk management 4 (1), 131-141, 2008 | 117 | 2008 |
| Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate A Tenenbaum, EZ Fisman, V Boyko, M Benderly, D Tanne, M Haim, ... Archives of internal medicine 166 (7), 737-741, 2006 | 107 | 2006 |
| Relation between renal function and outcomes in patients with non–ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research … I Goldenberg, I Subirana, V Boyko, J Vila, R Elosua, G Permanyer-Miralda, ... Archives of internal medicine 170 (10), 888-895, 2010 | 104 | 2010 |
| C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease D Tanne, M Benderly, U Goldbourt, M Haim, A Tenenbaum, EZ Fisman, ... Stroke 37 (7), 1720-1724, 2006 | 90 | 2006 |
| A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study D Tanne, M Benderly, U Goldbourt, V Boyko, D Brunner, E Graff, ... The American journal of medicine 111 (6), 457-463, 2001 | 85 | 2001 |
| Correcting for multivariate measurement error by regression calibration in meta‐analyses of epidemiological studies Fibrinogen Studies Collaboration Statistics in medicine 28 (7), 1067-1092, 2009 | 77 | 2009 |
| Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up EZ Fisman, A Tenenbaum, M Benderly, U Goldbourt, S Behar, M Motro Cardiology 91 (3), 195-202, 1999 | 71 | 1999 |
| Contribution of acute-phase proteins and cardiovascular risk factors to erythrocyte aggregation in normolipidemic and hyperlipidemic individuals X Weng, GO Roederer, R Beaulieu, G Cloutier Thrombosis and haemostasis 80 (12), 903-908, 1998 | 71 | 1998 |
| Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study E Barasch, M Benderly, E Graff, S Behar, H Reicher-Reiss, A Caspi, ... Journal of clinical epidemiology 48 (6), 757-765, 1995 | 68 | 1995 |
